This website uses cookies to enhance the user experience.
M

MEDEMA NORGE AS966 250 003

Purchase and sale
Limited company
Stamveien 6 1481 HAGAN, Norge

MEDEMA NORGE AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
30 years
since Mar 12, 1995
Type
Limited company
VAT registered
Yes
Number of employees
40

Ownership

Number of shares and share classes
202,500
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
275,613,480
NOK
Annual total result 2024
-317,296
NOK
Total equity 2024
30,649,228
NOK
Last update: Jul 14, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
28.38 %
indirectly

Board

NameRoleShares
Chairman
28.38 %
indirectly
Board Member-
Alternate Member
5.41 %
indirectly
Board Member
7.46 %
indirectly
Alternate Member-
Board Member-

Others

NameRoleShares
B
BDO AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
28.38 %
indirectly
-
23.56 %
indirectly
Board Member
7.46 %
indirectly
-
7.46 %
indirectly
-
7.46 %
indirectly
-
7.46 %
indirectly
Alternate Member
5.41 %
indirectly
-
5.41 %
indirectly
-
2.7 %
indirectly
-
2.7 %
indirectly
Last update: Apr 12, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
M
MEDEMA-GRUPPEN AS
Ordinary shares
202,500
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -398,377
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
275,613,480
265,339,960
192,955,907
203,558,252
Annual Total Result
-317,296
-7,669,552
-5,563,190
6,489,351
Total assets
80,878,446
90,698,914
60,149,166
55,733,837
Total liabilities
50,229,217
61,779,198
28,810,706
20,876,786
Total equity
30,649,228
28,919,716
31,338,461
34,857,051

P&L

Year2024202320222021
Total operating income
275,613,480
265,339,960
192,955,907
203,558,252
Total operating costs
269,749,036
268,201,123
192,640,333
192,907,821
Operating result
5,864,444
-2,861,162
315,573
10,650,432
Financial income/costs
-6,217,241
-6,956,736
-7,439,223
-2,263,881
Profit before tax
-352,797
-9,817,899
-7,123,650
8,386,550
Total tax & extraordinary income/cost
-35,501
-2,148,347
-1,560,460
1,897,199
Annual Total Result
-317,296
-7,669,552
-5,563,190
6,489,351

Balance overview

Year2024202320222021
Total fixed assets
10,054,561
7,399,259
2,246,644
2,453,701
Total current assets
70,823,885
83,299,656
57,902,523
53,280,136
Total assets
80,878,446
90,698,914
60,149,166
55,733,837
Short term debt
46,517,867
57,449,296
24,480,804
20,876,786
Long term debt
3,711,350
4,329,902
4,329,902
0
Total liabilities
50,229,217
61,779,198
28,810,706
20,876,786
Contributed capital
32,841,665
30,794,857
25,544,050
23,499,450
Retained earnings
-2,192,437
-1,875,141
5,794,411
11,357,601
Total equity
30,649,228
28,919,716
31,338,461
34,857,051
Total equity and liabilities
80,878,445
90,698,914
60,149,166
55,733,837

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods